Circulating clonotypic B cells in the biology of multiple myeloma: Speculations on the origin of myeloma

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 375-383

  Pilarski, Linda M ^a   Masellis Smith, Anna ^a   Szczepek, Agnieszka ^a   Mant, Michael J ^a   Belch, Andrew R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Circulating clonotypic B cells biology; Multiple myeloma; Origin of myeloma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

APOPTOSIS; B LYMPHOCYTE; CELL CYCLE; CELL TRANSFORMATION; HUMAN; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0029821850     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054775     Document Type: Review

References (56)

1. Bergsagel, P. L., Masellis Smith, A., Szczepek, A., Mant, M. J., Belch, A. R. and Pilarski, L. M. (1995) In multiple myeloma, clono-typic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56 and monotypic immunoglobulin light chain. Blood, 85, 436-447.
2. Zola, H., Mcardle, P. J., Bradford, T., Weedon, H., Yasui, H. and Kurosawa, Y. (1991) Preparation and characterization of a chimeric CD19 monoclonal antibody. Immunol. Cell Biol., 69, 411-122.
3. Pietersz, G. A., Li, W. J., Sutton, V. R., Burgess, J., McKenzie, I. F. C., Zola, H. and Trapani, J. A. (1995) In vitro and in vivo anti-tumor-activity of a chimeric anti-CD 19 antibody. Cancer Immunol. Immunother., 41, 53-60.
4. Jensen, G. S., Mant, M. J., Belch, A. J., Berensen, J. R., Ruether, B. A. and Pilarski, L. M. (1991) Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711-719.
5. Jensen, G. S., Belch, A. R., Mant, M. J., Ruether, B. A., Yacyshyn, B. R. and Pilarski, L. M. (1992) Expression of multiple beta-1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am. J. Hemalol., 43, 29-36.
6. Jensen, G. S., Belch, A. R., Kherani, F., Mant, M. J., Ruether, B. A. and Pilarski, L. M. (1992) Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand. J. Immunol., 36, 843-853.
7. Pilarski, L. M. (1995) CD19+ B cells in myeloma:Response to Letter to the Editor. Blood, 85, in press.
8. MacKenzie, M. R., Paglieroni, T. and Caggiano, V. (1991) CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients. Am. J. Hematol., 37, 163-166.
9. Pilarski, L. M. and Jensen, G. S. (1993) Expression of CD45 isoforms (leukocyte common antigen) and adhesion molecules during normal and abnormal B lymphocyte development. Advances in Molecular and Cellular Immunology, 1B, 75-117.
10. Pilarski, L. M. and Jensen, G. S. (1992) Monoclonal circulating B cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/Oncology Clinics of North America, 6, 297-322.
11. Witzig, T. E., Dhodapkar, M. V., Kyle, R. A. and Greipp, P. R. (1993) Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer, 72, 108-113.
12. Pilarski, L. M., Masellis Smith, A., Belch, A. R., Yang, B., Savani, R. C. and Turley, E. A. (1994) RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: A mediator in B cell malignancy? Leuk. Lymphoma, 14, 363-374.
13. Pilarski, L. M., Mant, M. M. and Belch, A. R. (1994) Circulating, monoclonal, multi-drug resistant B cells may comprise the malignant stem cells population in multiple myeloma. : in Challenges in Modem Medicine. Eds. F. Dammaco and B. Barlogie, 4, 31-39.
14. Bergsagel, P. L., Masellis-Smith, A., Belch, A. R. and Pilarski, L. M. (1994) The blood B cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements. Current Topics in Microbiol. Immunol., 199, 17-24.
15. Belch, A. R., Bergsagel, P. L., Szczepek, A.; Lansdorp, P. and Pilarski, L. M. (1994) CD34+ B cells in the blood of patients with multiple myeloma express clonotypic IgH sequences. Blood, 84, 385a.
16. Billadeau, D., Quam, L., Thomas, W., Kay, M., Greipp, P., Kyle, R., Oken, M. M. and Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
17. Billadeau, D., Ahmann, G., Greipp, P. and van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med., 178, 1023-1031.
18. Pilarski, L. M. and Belch, A. J. (1994) Circulating monoclonal B cells expressing p-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood, 83, 724-736.
19. Pilarski, L. M. and Belch, A. R. (1995) Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma; Implications for treatment. Leuk. Lymphoma, 17, 367-374.
20. Meltzer, A. (1990) Dormancy and breast cancer. J. Surg. Oncol., 43, 181-188.
21. Wheelock, E. F., Weinhold, K. J. and Levich, J. (1981) The tumor dormant state. Adv. Cancer Res., 34, 107-140.
22. Woodruff, M. (1982) Interaction of cancer and host. The Walter Hubert Lecture. Br. J. Cancer, 46, 313-322.
23. Holmgren, L., O'Reilley, M. S. and Folkman, J. (1995) Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med., 1, 149-153.
24. Schuermann, R. H., Racila, E., Tucker, T., Yefenof, E., Street, N., Vitetta, E., Picker, L. and Uhr, J. W. (1994) Lyn tyrosine kinase signais cell cycle arrest but not apoptosis in B lineage lymphoma cells. Proc. Nat. Acad. Sci. USA, 91, 4048-1052.
25. Wyllie, A. H. (1992) Apoptosis and the regulation of cell numbers in normal and malignant tissues: an overview. Cancer Metastasis Rev., 11, 95-103.
26. Yefenof, E., Picker, L. J., Scheuermann, R. H., Vitetta, E. S., Street, N. E., Tucker, T. F. and Uhr, J. W. (1993) Induction of B cell tumor dormancy by anti-idiotypic antibodies. Curr. Opinion. Immunol., 5, 740-744.
27. Racila, E., Scheuermann, R. H., Picker, L. J., Yefenof, E., Tucker, T., Chang, W., Marches, R., Street, N. E., Vitetta, E. S. and Uhr, J. W. (1995) Tumor dormancy and cell signalling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J. Exp. Med., 181, 1539-1550.
28. Yefenof, E., Picker, L. J., Schuermann, R. H., Tucker, T. F., Vitetta, E. S. and Uhr, J. W. (1993) Cancer Dormancy: isolation and characterization of dormant lymphoma cells. Proc. Nat. Acad. Sci. USA, 90, 1829-1833.
29. Williamson, A. R. and Askonas, B. A. (1972) Senescence of an antibody forming cell clone. Nature, 238, 337-379.
30. Urbain, J., Wikler, M., Franssen, J. D. and Colligon, C. (1977) Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proc. Nat. Acad. Sci. USA, 74, 5126-5130.
31. Kaplan, D. R., Quintans, J. and Kohler, H. (1978) Clonal Dominance: Loss and restoration in adoptive transfer. Proc. Nat. Acad. Sci. USA. 75, 1967-1970.
32. Schalch, W., Wright, J. K., Rodkey, L. S. and Braun, D. G. (1979) Clonal dominance of low affinity antibodies in rabbit hyperimmune anti-streptococcal group A variant polysaccharide antisera. Eur. J. Immunol., 9, 145-149.
33. Bordenave, G. R. (1976) Idiotypic specificities of rabbit anti-salmonella abortus equi antibodies in successive transfers in irradiated rabbits. Annal. Immunol., 127, 375-395.
34. Eitlinger, H. M., Julius, M. H. and Heusser, C. H. (1982) Mechanism of clonal dominance in the murine anti-phosphorylcholine response: I. Relation between antibody avidity and clonal dominance. J. Immunol., 128, 1685-1691.
35. Fung, J. and Kohler, H. (1980) Late clonal selection and expansion of the TEPC-15 germ line specificity. J. Exp. Med., 152,1 262-1273.
36. Askonas, B. A. and Williamson, A. R. (1972) Dominance of a cell clone forming antibody to DNP. Nature, 238, 339-341.
37. Pruzanski, W., Gidon, M. S. and Roy, A. (1980) Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosis. Clin. Immunol. Immunopathol., 17, 280-286.
38. Cone, L. and Uhr, J. W. (1964) Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma. J. Clin. Invest., 43, 2241-2248.
39. Pilarski, L. M., Mant, M. J., Ruether, B. A. and Belch, A. (1984) Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J. Clin. Invest., 74, 1301-1305.
40. Pilarski, L. M., Ruether, B. A. and Mant, M. J. (1985) Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. I. Lack of correlation between the number of cells potentially able to secrete IgM and serum IgM levels. J. Clin. Invest., 75, 2024-2029.
41. Pilarski, L. M., Andrews, E. J., Mant, M. J. and Ruether, B. A. (1986) Humoral immune deficiency in multiple myeloma patients due to compromised B cell function. J. Clin. Immunol., 6, 491-501.
42. Pilarski, L. M., Andrews, E. J., Serra, H. M., Ruether, B. A. and Mant, M. J. (1989) Comparative analysis of immunodeficiency between patients with gammopathy of undetermined significance and patients with untreated myeloma. Scand. J. Immunol., 29, 217-228.
43. Pilarski, L. M., Piotrowska-Krezolek, M., Gibney, D. J., Winger, L., Winger, C., Mant, M. J. and Ruether, B. A. (1985) Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab')2 region determinants on immunoglobulin. J. Clin. Immunol., 5, 275-284.
44. Pilarski, L. M., Mant, M. J. and Ruether, B. A. (1987) Review: Analysis of immunodeficiency in multiple myeloma: Observations and hypothesis. J. Clin. Lab. Anal., 1, 214-288.
45. Masellis-Smith, A., Belch, A. R., Mant, M. J., Turley, E. A. and Pilarski, L. M. (1994) Circulating monoclonal B cells in myeloma adhere to bone marrow (BM) fibroblasts and have motile behavior, but BM plasma cells are sessile. Blood, 84, 171a.
46. Masellis-Smith, A., Belch, A. R., Mant, M. J., Turley, E. A. and Pilarski, L. M. (1996) Hyaluronan-dependent motility of B cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: Alternate usage of RHAMM and CD44. Blood vol. in press.
47. Bergsagel, P. L., Belch, A. R. and Pilarski, L. M. (1994) The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation. Blood, 84, 524a.
48. Entwistle, J., Zhang, S., Yang, B., Wong, C., Hall, C. L., Curpen, G., Mowat, M., Greenberg, A. H. and Turley, E. A. (1995) Cloning and characterization of the gene encoding the hyaluronan receptor RHAMM: the role of a secreted isoform in the regulation of focal adhesion formation. Gene vol. in press.
49. Wang, C., Entwhistle, J., Hou, G., Li, Q. and Turley, E. A. (1996) The characterization of a human RHAMM cDNA: conservation of the hyaluronan binding domains. Gene vol. in press.
50. Hall, C. L., Wang, C., Lange, L. and Turley, E. A. (1994) Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell. Biol., 126, 575-588.
51. Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Savani, R. C., Greenberg, A. H. and Turley, E. A. (1995) Overexpression of the hyaluronan receptor RHAMM is transforming, and is required for H-ras transformation. Cell, 82, 19-28.
52. Turley, E. A., Belch, A. R., Poppema, S. and Pilarski, L. M. (1993) Expression and function of a receptor for hyaluronan-mediated motility (RHAMM) on normal and malignant B lymphocytes. Blood, 81, 446-453.
53. T., S. R., Sherwood, S. W., Hill, A. B. and Johnston, R. N. (1986) Overreplication and recombination of DNA in higher eukaryotes: Potential consequences and biological implications. Proc. Nat. Acad. Sci. USA, 83, 2157-2161.
54. Perry, M. E., Commane, M. and Stark, G. (1992) Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. Proc. Nat. Acad. Sci. USA, 89, 8112-8116.
55. Hoy, C. A., Rice, G. C., Kovacs, M. and Schimke, R. T. (1987) Over-replication of DNA in S phase Chinese hamster ovary cells after DNA synthesis inhibition. J. Biol. Chem., 262, 11927-11934.
56. Smith, K. A., Gorman, P. A., Stark, M. B., Groves, R. P. and Stark, G. R. (1990) Distinctive chromosomal structures are formed very early in the amplification of CAD genes in syrian hamster cells. Cell, 63, 1219-1227.